Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophyElise M. N. Ferré, Michail S. Lionakis, Kimberly Romito et al.|JCI Insight|2016Cited by 304
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trialChristopher Koh, Theo Heller, Laëtitia Canini et al.|The Lancet Infectious Diseases|2015Cited by 262